Efficacy and Safety of Hetrombopag in Preventing Chemotherapy-induced Thrombocytopenia in Gastrointestinal Tumors
NCT07492693
·
clinicaltrials.gov ↗
PHASE2
Phase
RECRUITING
Status
40
Enrollment
OTHER
Sponsor class
Conditions
Chemotherapy-induced Thrombocytopenia (CIT) in Patients With Gastrointestinal Tumors
Interventions
DRUG:
Hetrombopag
Sponsor
Changhai Hospital